DAYTONA BEACH, Fla. – NASCAR is teaming up with Janssen Pharmaceuticals, Inc. to help race fans who are at risk for or are living with blood clots.
Janssen, the maker of XARELTO (rivaroxaban), a medicine used to treat and help prevent blood clots, is now the official cardiovascular partner of NASCAR.
“We are encouraged to see Janssen Pharmaceuticals’ level of dedication to helping fans affected by blood clots,” said Jim O’Connell, NASCAR chief sales officer. “We welcome them to the NASCAR family, not only as an official partner but also as a race entitlement and team sponsor.”
Blood clots have hit close to home for the NASCAR community. Brian Vickers, full-time driver of the No. 55 Aaron’s Dream Machine Toyota for Michael Waltrip Racing in the NASCAR Sprint Cup Series, recently overcame his second episode with the condition.
Having completed his treatment with XARELTO and being cleared by his physician, Vickers is once again competing again in the NASCAR Sprint Cup Series.
“I’m so grateful for all of the fans who have reached out to me to show their support,” said Vickers. “When I had my first deep vein thrombosis in 2010, I did everything I could to treat it and get back to racing. It worked, but the drug I was prescribed required me to have my blood drawn a lot and avoid certain foods. Last year when I developed another clot last year my doctor prescribed me XARELTO, which didn’t require me to have my blood checked regularly or change my diet.”